These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2305 related articles for article (PubMed ID: 33572480)

  • 1. Human Milk Antibodies Against S1 and S2 Subunits from SARS-CoV-2, HCoV-OC43, and HCoV-229E in Mothers with A Confirmed COVID-19 PCR, Viral SYMPTOMS, and Unexposed Mothers.
    Demers-Mathieu V; DaPra C; Mathijssen G; A Sela D; M Jarvinen K; Seppo A; Fels S; Medo E
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33572480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Previous viral symptoms and individual mothers influenced the leveled duration of human milk antibodies cross-reactive to S1 and S2 subunits from SARS-CoV-2, HCoV-229E, and HCoV-OC43.
    Demers-Mathieu V; DaPra C; Mathijssen GB; Medo E
    J Perinatol; 2021 May; 41(5):952-960. PubMed ID: 33649442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of Serum Cross-Reactive Antibodies and Memory Response to SARS-CoV-2 in Prepandemic and Post-COVID-19 Convalescent Samples.
    Shrwani K; Sharma R; Krishnan M; Jones T; Mayora-Neto M; Cantoni D; Temperton NJ; Dobson SL; Subramaniam K; McNamara PS; Cunliffe NA; Turtle L; Zhang Q
    J Infect Dis; 2021 Oct; 224(8):1305-1315. PubMed ID: 34161567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Difference in levels of SARS-CoV-2 S1 and S2 subunits- and nucleocapsid protein-reactive SIgM/IgM, IgG and SIgA/IgA antibodies in human milk.
    Demers-Mathieu V; Do DM; Mathijssen GB; Sela DA; Seppo A; Järvinen KM; Medo E
    J Perinatol; 2021 Apr; 41(4):850-859. PubMed ID: 32873904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-reactive antibody against human coronavirus OC43 spike protein correlates with disease severity in COVID-19 patients: a retrospective study.
    Guo L; Wang Y; Kang L; Hu Y; Wang L; Zhong J; Chen H; Ren L; Gu X; Wang G; Wang C; Dong X; Wu C; Han L; Wang Y; Fan G; Zou X; Li H; Xu J; Jin Q; Cao B; Wang J
    Emerg Microbes Infect; 2021 Dec; 10(1):664-676. PubMed ID: 33734013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping SARS-CoV-2 Antibody Epitopes in COVID-19 Patients with a Multi-Coronavirus Protein Microarray.
    Camerini D; Randall AZ; Trappl-Kimmons K; Oberai A; Hung C; Edgar J; Shandling A; Huynh V; Teng AA; Hermanson G; Pablo JV; Stumpf MM; Lester SN; Harcourt J; Tamin A; Rasheed M; Thornburg NJ; Satheshkumar PS; Liang X; Kennedy RB; Yee A; Townsend M; Campo JJ
    Microbiol Spectr; 2021 Oct; 9(2):e0141621. PubMed ID: 34704808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody Mediated Immunity to SARS-CoV-2 and Human Coronaviruses: Multiplex Beads Assay and Volumetric Absorptive Microsampling to Generate Immune Repertoire Cartography.
    Wang J; Li D; Zhou Q; Wiltse A; Zand MS
    Front Immunol; 2021; 12():696370. PubMed ID: 34386006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralizing and binding activities against SARS-CoV-1/2, MERS-CoV, and human coronaviruses 229E and OC43 by normal human intravenous immunoglobulin derived from healthy donors in Japan.
    Kubota-Koketsu R; Terada Y; Yunoki M; Sasaki T; Nakayama EE; Kamitani W; Shioda T
    Transfusion; 2021 Feb; 61(2):356-360. PubMed ID: 33104267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are higher antibody levels against seasonal human coronaviruses associated with a more robust humoral immune response after SARS-CoV-2 vaccination?
    Asamoah-Boaheng M; Grunau B; Karim ME; Jassem AN; Bolster J; Marquez AC; Scheuermeyer FX; Goldfarb DM
    Front Immunol; 2022; 13():954093. PubMed ID: 36159791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of S1-, S2-, and NCP-Specific IgM, IgA, and IgG Antibody Kinetics in Acute SARS-CoV-2 Infection by a Microarray and Twelve Other Immunoassays.
    Semmler G; Traugott MT; Graninger M; Hoepler W; Seitz T; Kelani H; Karolyi M; Pawelka E; Aragón de La Cruz S; Puchhammer-Stöckl E; Aberle SW; Stiasny K; Zoufaly A; Aberle JH; Weseslindtner L
    J Clin Microbiol; 2021 Apr; 59(5):. PubMed ID: 33602698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-RBD IgG antibodies from endemic coronaviruses do not protect against the acquisition of SARS-CoV-2 infection among exposed uninfected individuals.
    Adami FL; de Castro MV; Almeida BDS; Daher IP; Yamamoto MM; Souza Santos K; Zatz M; Naslavsky MS; Rosa DS; Cunha-Neto E; de Oliveira VL; Kalil J; Boscardin SB
    Front Immunol; 2024; 15():1396603. PubMed ID: 38846944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential pre-pandemic breast milk IgA reactivity against SARS-CoV-2 and circulating human coronaviruses in Ugandan and American mothers.
    Egwang TG; Owalla TJ; Okurut E; Apungia G; Fox A; De Carlo C; Powell RL
    Int J Infect Dis; 2021 Nov; 112():165-172. PubMed ID: 34547496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a multiplexed coronavirus antigen array for detection of SARS-CoV-2 specific IgG in COVID-19 convalescent plasma.
    Huey L; Andersen G; Merkel PA; Morrison TE; McCarthy M; DomBourian MG; Annen K; Dawson ED; Rowlen KL; Knight V
    J Immunol Methods; 2021 Oct; 497():113104. PubMed ID: 34303688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S Protein-Reactive IgG and Memory B Cell Production after Human SARS-CoV-2 Infection Includes Broad Reactivity to the S2 Subunit.
    Nguyen-Contant P; Embong AK; Kanagaiah P; Chaves FA; Yang H; Branche AR; Topham DJ; Sangster MY
    mBio; 2020 Sep; 11(5):. PubMed ID: 32978311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence and SARS-CoV-2 cross-reactivity of endemic coronavirus OC43 and 229E antibodies in Finnish children and adults.
    Tamminen K; Salminen M; Blazevic V
    Clin Immunol; 2021 Aug; 229():108782. PubMed ID: 34118402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-existing anti-HCoV-OC43 immunity influences the durability and cross-reactivity of humoral response to SARS-CoV-2 vaccination.
    Hu C; Wang Z; Ren L; Hao Y; Zhu M; Jiang H; Wang S; Li D; Shao Y
    Front Cell Infect Microbiol; 2022; 12():978440. PubMed ID: 36118022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HCoV- and SARS-CoV-2 Cross-Reactive T Cells in CVID Patients.
    Steiner S; Sotzny F; Bauer S; Na IK; Schmueck-Henneresse M; Corman VM; Schwarz T; Drosten C; Wendering DJ; Behrends U; Volk HD; Scheibenbogen C; Hanitsch LG
    Front Immunol; 2020; 11():607918. PubMed ID: 33424856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The durability of immunity against reinfection by SARS-CoV-2: a comparative evolutionary study.
    Townsend JP; Hassler HB; Wang Z; Miura S; Singh J; Kumar S; Ruddle NH; Galvani AP; Dornburg A
    Lancet Microbe; 2021 Dec; 2(12):e666-e675. PubMed ID: 34632431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) study: an observational cohort study of SARS-CoV-2 infection and vaccination in healthcare workers.
    Jackson-Thompson BM; Goguet E; Laing ED; Olsen CH; Pollett S; Hollis-Perry KM; Maiolatesi SE; Illinik L; Ramsey KF; Reyes AE; Alcorta Y; Wong MA; Davies J; Ortega O; Parmelee E; Lindrose AR; Moser M; Graydon E; Letizia AG; Duplessis CA; Ganesan A; Pratt KP; Malloy AM; Scott DW; Anderson SK; Snow AL; Dalgard CL; Powers JH; Tribble D; Burgess TH; Broder CC; Mitre E
    BMC Infect Dis; 2021 Jun; 21(1):544. PubMed ID: 34107889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgG Against Human Betacoronavirus Spike Proteins Correlates With SARS-CoV-2 Anti-Spike IgG Responses and COVID-19 Disease Severity.
    Wang J; Li D; Cameron A; Zhou Q; Wiltse A; Nayak J; Pecora ND; Zand MS
    J Infect Dis; 2022 Aug; 226(3):474-484. PubMed ID: 35091739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 116.